eBrands
Venture Round in 2025
eBrands is a technology-driven consumer brand company that focuses on acquiring and scaling emerging e-commerce brands primarily in the Sports and Beauty sectors. The company identifies promising market leaders and operates these brands across multiple channels in the United States, Europe, and Asia. By targeting small and medium-sized businesses with high potential, eBrands aims to enhance their growth and visibility in global marketplaces. This approach not only provides a platform for successful brands but also offers entrepreneurs an opportunity for a smooth exit from their ventures.
ESL Shipping
Venture Round in 2023
ESL Shipping is a dry-bulk sea transport company specializing in the transportation of products and raw materials for the steel, energy, and mining industries. The company ensures year-round shipping services while also providing loading and unloading operations for large oceangoing vessels at sea. ESL Shipping focuses on sustainable solutions, offering fossil-free sea transportation and services tailored to meet the needs of various industries. Their expertise includes transshipments at sea, handling dry bulk and breakbulk cargo, and managing project cargoes, with capabilities for operations in arctic areas.
Haltian
Private Equity Round in 2023
Haltian specializes in the design and development of Internet of Things (IoT) solutions and wireless technologies tailored for global consumer electronics and telecommunications companies. The company offers a range of services, including the Empathic Building digital twin service, which enhances the management of smart buildings, and the Thingsee platform, which accelerates IoT deployments for large-scale applications. Through its innovative products and services, Haltian aims to simplify daily tasks for end-users while providing businesses with actionable data to inform their decision-making processes. By focusing on enhancing productivity, safety, employee satisfaction, and customer experience, Haltian supports clients in effectively expanding their digital operations.
IQM Quantum Computers
Series A in 2022
IQM Quantum Computers, founded in 2018 and headquartered in Espoo, Finland, specializes in developing and manufacturing hardware systems for quantum computing. The company focuses on scalable hardware solutions utilizing superconducting technology to build quantum processors for universal quantum computers. By concentrating on practical applications, IQM aims to enhance quantum computing capabilities and address challenges faced by various industries and society. As a spin-out from Aalto University and the VTT Technical Research Centre of Finland, IQM has achieved significant advancements in areas such as thermal management, which are crucial for improving computational speed and information accuracy. The company's innovations position it as a leader in the global pursuit of large-scale quantum computing solutions. IQM also offers access to its hardware for research laboratories and supercomputing centers, helping businesses reduce error rates that currently limit computing performance.
eBrands
Venture Round in 2022
eBrands is a technology-driven consumer brand company that focuses on acquiring and scaling emerging e-commerce brands primarily in the Sports and Beauty sectors. The company identifies promising market leaders and operates these brands across multiple channels in the United States, Europe, and Asia. By targeting small and medium-sized businesses with high potential, eBrands aims to enhance their growth and visibility in global marketplaces. This approach not only provides a platform for successful brands but also offers entrepreneurs an opportunity for a smooth exit from their ventures.
Foxberry
Corporate Round in 2019
Foxberry is an independent index manager based in Canary Wharf, London, specializing in index management for the financial sector. The company provides expertise in creating, governing, and trading financial indices across various asset classes. Foxberry is regulated by the Financial Conduct Authority and is registered as a benchmark administrator under the EU benchmark regulation. The firm offers a range of services, including structuring, analysis, and technological capabilities that are typically associated with investment banks. By acting as an independent partner, Foxberry aims to enhance the market for financial indices, providing clients with options for sustainability, analytics, and index creation. With over a decade of experience, the Foxberry team is well-equipped to support diverse financial needs.
Mediverkko
Series B in 2012
Mediverkko is a Finland-based healthcare and social service provider that caters to both private and municipal customers. Established in 2002, the company offers a comprehensive range of services, including healthcare, dental clinics, elderly care, and child welfare services, primarily for public sector partners. Mediverkko focuses on delivering cost-effective health and care solutions. In 2014, the company was acquired by Mehiläinen, further enhancing its capacity to serve its clients effectively.
Vivoxid
Venture Round in 2005
Vivoxid Ltd. develops, manufactures, and markets biomaterial products for the medical device sector. The company offers MetAlive soft tissue attachment technology for implant surfaces. BonAlive bioactive glass and biodegradable polymer composite products in bone reconstruction and FiberLive biodegradable fiberglass composites for load-bearing biodegradable implants. It has distributors in northern Europe, the United Kingdom, southern Europe, Italy, Greece, Turkey, the Middle East, and Saudi Arabia. The company was founded in 2001 and is based in Turku, Finland.
Ipsat Therapies
Series C in 2005
Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.